Overview
Andreas Lennartsson practices in Huddinge, Sweden. Mr. Lennartsson is rated as an Advanced expert by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Acute Myeloblastic Leukemia with Maturation, Acute Myeloblastic Leukemia without Maturation, and Wilms Tumor.
His clinical research consists of co-authoring 45 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of WT1-Related Wilms Tumor Syndromes.
Locations
Stockholm, AB, Sweden
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloblastic Leukemia with MaturationMr. Lennartsson isAdvanced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Mr. Lennartsson isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Wilms TumorMr. Lennartsson isAdvanced. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesMr. Lennartsson isAdvanced. Learn about WT1-Related Wilms Tumor Syndromes.
- Experienced
- LeukemiaMr. Lennartsson isExperienced. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)Mr. Lennartsson isExperienced. Learn about Myelodysplastic Syndrome (MDS).